Legence (LGN) Stock Price, Quote, News & History | Benzinga

SPY777.39+0.02%QQQ758.78+0.14%BTC/USD83,186.48−2.76%DIA510.94−0.02%GLD376.04+0.04%TLT77.09−0.07%

Legence Corp (LGN) Stock Price, Quote, News & History

LGNNASDAQ

Trade with Public

Trade with Public

$53.35

-2.99-5.31%

Last update: Oct 7, 4:00 PM

$53.35

-2.99-5.31%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$54.52

Close

$53.35

Volume / Avg.

997.89K / 1.15M

Day Range

$52.04 - $54.95

52 Wk Range

29.45 - 107.24

Market Cap

$4.10B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

5.9%

Days to Cover

4.16

Recent Legence Corp. News

These Analysts Revise Their Forecasts On Legence Following Q2 Results

Legence Corp (NASDAQ: LGN) reported mixed Q2 results, missing earnings estimates but beating sales expectations. Analysts lowered price targets.

Avi Kapoor

Legence Stock Retreats Despite Triple-Digit Revenue Growth And Raised Outlook

Legence (NASDAQ: LGN) shares reversed Thursday, turning lower despite Q1 revenue beat, above-estimate Q2 guidance and raised FY26 outlook.

Dylan Berman

S&P 500 Hits Another Record High: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

CNN Business Fear & Greed Index measures market sentiment with a range of 0-100. Its reading of 65.8 on Wed indicated Greed despite slight improvement.

Avi Kapoor

Dillard's, Cisco Systems And 3 Stocks To Watch Heading Into Thursday

U.S. stock futures up, Dillard's, Cisco, Applied Materials, Doximity, Legence expected to report earnings. Stocks to watch. Photo via Shutterstock.

Avi Kapoor

This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday

Top analysts change outlook on Hyperfine Inc, Legence, and Aktis Oncology with Buy/Outperform ratings and price targets. See other analysts' views.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

388.83M

Investing Cash Flow (TTM)

-362.54M

Financing Cash Flow (TTM)

167.79M

Free Cash Flow (TTM)

323.18M

Capital Expenditure (TTM)

-65.64M

Net Change in Cash (TTM)

194.08M

Analyst Trends and Forecast

4

Apr

3

1

May

1

Jun

2

Jul

6

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$5.24B

PE Ratio (TTM)

-

PE Ratio (FWD)

15.92

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.16

PB Ratio (TTM)

7.22

Earnings Yield % (TTM)

-0.57%

Earnings Yield % (FWD)

6.28%

EV / EBITDA (TTM)

33.33

Price / EBITDA (TTM)

27.57

Price / Free Cash Flow (TTM)

13.40

Book Value / Share

$7.81

Company Debt

Total Debt

$1.03B

LT Debt

$1.01B

LT Debt Issuance (TTM)

$282.14M

LT Debt Repayment (TTM)

-$883.17M

Total Cash

$291.98M

Debt to Equity

1.99

Issuance of Debt (TTM)

-$601.02M

Repayment of Debt (TTM)

-$883.17M